Protect Military Dependents Act

Lobbying Report: July 1st -September 30th, 2025 (Action Fund)  Federal (under tobacco issue code)   Legislation:   Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 2064, Helping Tobacco Users Quit Act H.R. 1, One Big Beautiful Bill Act H. R. 901 (118th Congress), Disposable ENDS Product Enforcement Act of 2023 H.R. 2111, To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 H.R. 4404, the Hookah Clarification Act H.R. 9425 (118th Congress), the Tobacco User Fee Modernization Act of 2024 S. 819/H.R. 1798, End Tobacco Loopholes Act S. 2171/H.R.3855, a bill to prohibit smoking on premises of Veterans Health Administration facilities Issues: CDC FY 25 state National Tobacco Control Program grants CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping Congressional efforts to reduce e-cigarette and tobacco use FDA authority over tobacco products FDA authorization of tobacco products FDA destruction authority FDA enforcement against unauthorized e-cigarettes FDA multiagency task force to combat the distribution and sale of illegal e-cigarettes FDA tobacco user fees FDA track and trace system for tobacco products GAO report on federal efforts to address unauthorized e-cigarettes HHS reorganization FDAs proposed rule to prohibit menthol cigarettes FDA Proposed rule to set a maximum nicotine level for cigarettes Tobacco cessation in general U.S. Preventive Services Task Force Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  

Client expense: $480,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Lobbying Report: July 1st -September 30th, 2025 (Campaign)     Federal (under tobacco issue code)    Legislation:   Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 2064, Helping Tobacco Users Quit Act H.R. 1, One Big Beautiful Bill Act H. R. 901 (118th Congress), Disposable ENDS Product Enforcement Act of 2023 H.R. 2111, To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 H.R. 4404, the Hookah Clarification Act H.R. 9425 (118th Congress), the Tobacco User Fee Modernization Act of 2024 S. 819/H.R. 1798, End Tobacco Loopholes Act S. 2171/H.R.3855, a bill to prohibit smoking on premises of Veterans Health Administration facilities Issues: CDC FY 25 state National Tobacco Control Program grants CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping Congressional efforts to reduce e-cigarette and tobacco use FDA authority over tobacco products FDA authorization of tobacco products FDA destruction authority FDA enforcement against unauthorized e-cigarettes FDA multiagency task force to combat the distribution and sale of illegal e-cigarettes FDA tobacco user fees FDA track and trace system for tobacco products GAO report on federal efforts to address unauthorized e-cigarettes HHS reorganization FDAs proposed rule to prohibit menthol cigarettes FDA Proposed rule to set a maximum nicotine level for cigarettes Tobacco cessation in general U.S. Preventive Services Task Force Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  

Client expense: $30,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Lobbying Report: January 1st - March 31st, 2025 (Action Fund)  Federal (under tobacco issue code)   Legislation:   S. 4690/H.R. 9027 (118th Congress) - FY 25 Agriculture, Rural Development, and Food and Drug Administration, and Related Agencies Appropriations Bill S. 4942/H.R. 9029 (118th Congress) - FY 25 Labor, HHS, Education, and Related Agencies Appropriations Bill Tobacco User Fee Modernization Act Stop Chinese Vapes from Poisoning American Kids Act   H.R. 1798/S. 819 End Tobacco Loopholes Act H.R. 1968 - FY2025 Full-Year Continuing Appropriations and Extensions Act FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Bill FY 26 Labor Health and Human Services, Education, and Related Agencies Appropriations Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction (PROTECT) Act S.Con.Res.7 - Senate Budget Resolution   Issues   FDA regulation of e-cigarettes   FDA nicotine standard FDA tobacco user fees Youth e-cigarette use   CDC Office on Smoking and Health funding   Congressional efforts to reduce e-cigarette and tobacco use FDA rule on menthol cigarettes FDA rule on flavored cigars Department of Health and Human Services Reorganization FDA Authority over tobacco products Senate budget resolution Prevention and Public Health Fund WHO Withdrawal Agencies Visited:   Centers for Disease Control and Prevention   US House of Representatives   US Senate   Food and Drug Administration 

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE